摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(morpholin-4-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1λ6-1,2,6-thiadiazine-5-carboxamide | 936756-65-9

中文名称
——
中文别名
——
英文名称
N-(morpholin-4-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1λ6-1,2,6-thiadiazine-5-carboxamide
英文别名
6-benzyl-5-methyl-N-morpholin-4-yl-1,1-dioxo-1,2,6-thiadiazine-3-carboxamide
N-(morpholin-4-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1<sup>λ6</sup>-1,2,6-thiadiazine-5-carboxamide化学式
CAS
936756-65-9
化学式
C16H20N4O4S
mdl
——
分子量
364.425
InChiKey
MOMSLSHRCUXFIG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    99.7
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    4-氨基吗啉2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1λ6-1,2,6-thiadiazine-5-carboxylic acid ethyl ester三甲基铝 作用下, 以 正己烷二氯甲烷 为溶剂, 反应 24.0h, 以20%的产率得到N-(morpholin-4-yl)-2-benzyl-3-methyl-1,1-dioxo-1,2-dihydro-1λ6-1,2,6-thiadiazine-5-carboxamide
    参考文献:
    名称:
    Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity
    摘要:
    A series of new 2-substituted 1,1-dioxo-1,2,6-thiadiazine-5-carboxylate derivatives have been prepared from monosubstituted sulfamides in order to obtain N-substituted1,1-dioxo-1,2,6-thiadiazine-5-carboxamides as novel cannabinoid derivatives, analogues of Rimonabant (SR141716A). Their potential functional activity on cannabinoid receptors has been evaluated in vitro and in vivo in mice, showing that two compounds (37 and 39) behave as cannabinoid agonists in vitro. Their potency is lower than that of the reference compound, WIN 55,212-2, but their efficacy is similar to that of this cannabinoid agonist, although no in vivo activity is observed. Another derivative (38) behaves as a cannabinoid antagonist both in vitro and in vivo, being its efficacy and potency similar to that of the well-known antagonist SR141716A. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.07.056
点击查看最新优质反应信息